Skip to main content

Advertisement

SpringerLink
Log in

7RECENT Advances in Endoscopic Treatments for Gastroesophageal Reflux Disease

  • Esophagus (P Iyer, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

A Correction to this article was published on 30 July 2020

This article has been updated

Abstract

Purpose of review

There is a growing interest in minimally invasive approaches to the management of gastroesophageal reflux disease (GERD), including endoscopic GERD therapy. This review evaluates available endoscopic therapeutic options utilized in GERD management.

Recent findings

Application of radiofrequency energy at the esophagogastric junction (EGJ) reduces reflux symptoms, but esophageal acid exposure does not necessarily normalize, and esophageal sensation is compromised. Two approaches to the creation of a valve at the EGJ, the Medigus ultrasonic surgical stapler (ultrasound guided stapling of the gastric fundus to the EGJ) and EsophyX (fasteners to create a 270 ° partial fundoplication), improve symptoms and reduce esophageal acid burden, but long-term durability remains unknown. Endoscopic management is widely utilized for GERD complications.

Summary

Selecting the appropriate patient is key for therapeutic success with endoscopic GERD therapy. Patients with minimally disrupted EGJ barrier (< 2 cm hiatus hernia) and intact esophageal peristalsis are optimal candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Change history

  • 30 July 2020

    In the article, “7RECENT Advances in Endoscopic Treatments for Gastroesophageal Reflux Disease,” published in the September issue of Current Treatment Options in Gastroenterology, the title is printed in correctly.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–62 Criteria for conclusive diagnosis of GERD, borderline or inclusive criteria, and adjunctive evidence for GERD are described.

    Article  PubMed  Google Scholar 

  2. •• Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology 2017. A comprehensive description of management options for GERD.

  3. • Hillman L, Yadlapati R, Thuluvath AJ, et al. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Dis Esophagus. 2017;30:1–15. A discussion of medical management approaches for patients with GERD refractory to PPI therapy.

  4. • Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease. Surg Endosc. 2017;31:4865–82 An inclusive systematic review of available studies utilizing radiofrequency delivery for management of GERD.

    Article  PubMed  Google Scholar 

  5. Nehra AK, Alexander JA, Loftus CG, Nehra V. Proton pump inhibitors: review of emerging concerns. Mayo Clin Proc. 2018;93:240–6.

    Article  CAS  PubMed  Google Scholar 

  6. Bolier EA, Kessing BF, Smout AJ, Bredenoord AJ. Systematic review: questionnaires for assessment of gastroesophageal reflux disease. Dis Esophagus. 2015;28:105–20.

    Article  CAS  PubMed  Google Scholar 

  7. Savarino E, Zentilin P, Frazzoni M, Cuoco DL, Pohl D, Dulbecco P, et al. Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil. 2010;22:1061–e280.

    Article  CAS  PubMed  Google Scholar 

  8. Bredenoord AJ, Hemmink GJ, Smout AJ. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterol Motil. 2009;21:807–12.

    Article  CAS  PubMed  Google Scholar 

  9. Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29.

  10. • Gyawali CP, Roman S, Bredenoord AJ, et al. Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group. Neurogastroenterol Motil. 2017;29. A description of structural and motor esophagogastric junction abnormalities identified on manometry that contribute to pathophysiology of GERD.

  11. Frazzoni M, Piccoli M, Conigliaro R, Frazzoni L, Melotti G. Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol. 2014;20:14272–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. •• De Moura EGH, Sallum RAA, Nasi A, et al. Endoscopic polymer injection and endoluminal plication in treatment of gastroesophageal reflux disease: evaluation of long-term results. Endosc Int Open. 2018;6:E630–6 Patients that underwent polymer injection had improvement in GERD related scores at 12 months.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Cohen LB, Johnson DA, Ganz RA, Aisenberg J, Devière J, Foley TR, et al. Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. Gastrointest Endosc. 2005;61:650–8.

    Article  PubMed  Google Scholar 

  14. Helo N, Wu A, Moon E, Wang W. Visceral artery embolization after endoscopic injection of Enteryx for gastroesophageal reflux disease. J Radiol Case Rep. 2014;8:21–4.

    PubMed  PubMed Central  Google Scholar 

  15. Alzahrani A, Anvari M, Dallemagne B, et al. Surgical approach after failed enteryx injection for GERD. JSLS. 2007;11:97–100.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Ganz RA, Fallon E, Wittchow T, Klein D. A new injectable agent for the treatment of GERD: results of the Durasphere pilot trial. Gastrointest Endosc. 2009;69:318–23.

    Article  PubMed  Google Scholar 

  17. Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014;20:7730–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nabi Z, Reddy DN. Endoscopic management of gastroesophageal reflux disease: revisited. Clin Endosc. 2016;49:408–16.

    Article  PubMed  PubMed Central  Google Scholar 

  19. • Noar M, Squires P, Khan S. Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort. Surg Endosc. 2017;31:2854–62. Radiofrequency energy delivery to the lower esophageal sphincter reduces transient lower esophageal sphincter relaxations (TLESRs) through damage to the muscularis layer.

    Article  PubMed  Google Scholar 

  20. Arts J, Sifrim D, Rutgeerts P, Lerut A, Janssens J, Tack J. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease. Dig Dis Sci. 2007;52:2170–7.

    Article  CAS  PubMed  Google Scholar 

  21. Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125:668–76.

    Article  PubMed  Google Scholar 

  22. Triadafilopoulos G, DiBaise JK, Nostrant TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002;55:149–56.

    Article  PubMed  Google Scholar 

  23. Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1058–67 e1.

    Article  PubMed  Google Scholar 

  24. Pearl J, Pauli E, Dunkin B, Stefanidis D. SAGES endoluminal treatments for GERD. Surg Endosc. 2017;31:3783–90.

    Article  PubMed  Google Scholar 

  25. Committee ASoP, Muthusamy VR, Lightdale JR, et al. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81:1305–10.

    Article  Google Scholar 

  26. Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27:346–51.

    PubMed  PubMed Central  Google Scholar 

  27. •• Hedberg HM, Kuchta K, Ujiki MB. First experience with banded anti-reflux mucosectomy (ARMS) for GERD: feasibility, safety, and technique (with Video). J Gastrointest Surg. 2019;23:1274–8 Anti-reflux mucosectomy may be effective in certain patient populations.

    Article  PubMed  Google Scholar 

  28. • Hathorn KE, Jirapinyo P, Thompson CC. Endoscopic management of gastroesophageal reflux disease after sleeve gastrectomy by use of the antireflux mucosectomy procedure. VideoGIE. 2019;4:251–3 Anti-reflux mucosectomy can be potentially utilized after sleeve gastrectomy for treatment of gastroesophageal reflux.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29:220–9.

    Article  PubMed  Google Scholar 

  30. •• Kim HJ, Kwon CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE endoscopic stapling device. Surg Endosc. 2016;30:3402–8 In long term follow up, GERD scores improved off PPI therapy, and no serious adverse events were reported after the MUSE procedure was modified.

    Article  PubMed  Google Scholar 

  31. • Nabi Z, Reddy DN. Update on endoscopic approaches for the management of gastroesophageal reflux disease. Gastroenterol Hepatol (N Y). 2019;15:369–76 A detailed description of available endoscopic options for the management of GERD.

    Google Scholar 

  32. Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22:26–40.

    Article  PubMed  PubMed Central  Google Scholar 

  33. •• Trad KS, Barnes WE, Prevou ER, et al. The TEMPO trial at 5 years: Transoral Fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov. 2018;25:149–57 A significant reduction in GERD scores seen after TIF compared to PPI therapy alone. No serious adverse events were noted at 5 years.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Hunter JG, Kahrilas PJ, Bell RC, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148:324–33 e5.

    Article  CAS  PubMed  Google Scholar 

  35. •• Testoni PA, Testoni S, Distefano G, et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years. Endosc Int Open. 2019;7:E647–54 Ten year follow up data suggests patients that underwent TIF had lower GERD scores compared to pre-fundoplication.

    Article  PubMed  PubMed Central  Google Scholar 

  36. • Huang X, Chen S, Zhao H, et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc. 2017;31:1032–44 Systemic review of observational and randomized trials suggests benefit of TIF over PPI or sham procedure, although acid exposure was not improved compared to PPI therapy.

    Article  PubMed  Google Scholar 

  37. •• Weitzendorfer M, Spaun GO, Antoniou SA, et al. Clinical feasibility of a new full-thickness endoscopic plication device (GERDx) for patients with GERD: results of a prospective trial. Surg Endosc. 2018;32:2541–9 Patients undergoing GERDx had decreased DeMeester scores at three months, with 60% having normalization of scores during this time.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Piotet E, Escher A, Monnier P. Esophageal and pharyngeal strictures: report on 1,862 endoscopic dilatations using the Savary-Gilliard technique. Eur Arch Otorhinolaryngol. 2008;265:357–64.

    Article  PubMed  Google Scholar 

  39. Desai JP, Moustarah F. Esophageal stricture. Treasure Island: StatPearls; 2019.

    Google Scholar 

  40. Sami SS, Haboubi HN, Ang Y, Boger P, Bhandari P, de Caestecker J, et al. UK guidelines on oesophageal dilatation in clinical practice. Gut. 2018;67:1000–23.

    Article  PubMed  Google Scholar 

  41. Colon VJ, Young MA, Ramirez FC. The short- and long-term efficacy of empirical esophageal dilation in patients with nonobstructive dysphagia: a prospective, randomized study. Am J Gastroenterol. 2000;95:910–3.

    Article  CAS  PubMed  Google Scholar 

  42. Scolapio JS, Gostout CJ, Schroeder KW, Mahoney DW, Lindor KD. Dysphagia without endoscopically evident disease: to dilate or not? Am J Gastroenterol. 2001;96:327–30.

    Article  CAS  PubMed  Google Scholar 

  43. Hernandez LV, Jacobson JW, Harris MS. Comparison among the perforation rates of Maloney, balloon, and savary dilation of esophageal strictures. Gastrointest Endosc. 2000;51:460–2.

    Article  CAS  PubMed  Google Scholar 

  44. • Grooteman KV, Wong Kee Song LM, Vleggaar FP, et al. Non-adherence to the rule of 3 does not increase the risk of adverse events in esophageal dilation. Gastrointest Endosc. 2017;85:332–7 e1. An increased risk of perforation and adverse events are seen in malignant strictures when compared to benign strictures.

    Article  PubMed  Google Scholar 

  45. Chotiprasidhi P, Minocha A. Effectiveness of single dilation with Maloney dilator versus endoscopic rupture of Schatzki's ring using biopsy forceps. Dig Dis Sci. 2000;45:281–4.

    Article  CAS  PubMed  Google Scholar 

  46. • Walter B, Schmidbaur S, Rahman I, et al. The BougieCap - a new method for endoscopic treatment of complex benign esophageal stenosis: results from a multicenter study. Endoscopy. 2019;51:866–70. Description of a new device for endoscopic assessment and management of esophageal strictures.

  47. Raskin JB, Manten H, Harary A, Redlhammer DE, Rogers AI. Transendoscopic electrosurgical incision of lower esophageal (Schatzki) rings: a new treatment modality. Gastrointest Endosc. 1985;31:391–3.

    Article  CAS  PubMed  Google Scholar 

  48. • Zeng QS, Yang J, Liu W, et al. Endoscopic incision method for treatment of refractory esophageal stricture. VideoGIE. 2017;2:76–8. Description of the method for endoscopic incision to disrupt esophageal strictures.

  49. Hordijk ML, van Hooft JE, Hansen BE, Fockens P, Kuipers EJ. A randomized comparison of electrocautery incision with Savary bougienage for relief of anastomotic gastroesophageal strictures. Gastrointest Endosc. 2009;70:849–55.

    Article  PubMed  Google Scholar 

  50. •• Hasak S, Brunt LM, Wang D, et al. Clinical characteristics and outcomes of patients with postfundoplication dysphagia. Clin Gastroenterol Hepatol. 2019;17:1982–90 Post-fundoplication dysphagia can be managed with endoscopic dilation, but those with persistent dysphagia may require re-operation.

    Article  PubMed  Google Scholar 

  51. Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305:1969–77.

    Article  CAS  PubMed  Google Scholar 

  52. Yang H, Meun C, Sun X, Watson DI. Outcome following management of dysphagia after laparoscopic anti-reflux surgery. World J Surg. 2012;36:838–43.

    Article  PubMed  Google Scholar 

  53. Malhi-Chowla N, Gorecki P, Bammer T, Achem SR, Hinder RA, DeVault KR. Dilation after fundoplication: timing, frequency, indications, and outcome. Gastrointest Endosc. 2002;55:219–23.

    Article  PubMed  Google Scholar 

  54. Shaker A, Stoikes N, Drapekin J, Kushnir V, Brunt ML, Gyawali PC. Multiple rapid swallow responses during esophageal high-resolution manometry reflect esophageal body peristaltic reserve. Am J Gastroenterol. 2013;108:1706–12.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Sunjaya D, Podboy A, Blackmon SH, Katzka D, Halland M. The effect of pneumatic dilation in management of postfundoplication dysphagia. Neurogastroenterol Motil. 2017;29.

  56. •• Yadlapati R, Vaezi MF, Vela MF, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018;113:980–6 Selection of endoscopic modality for treatment of GERD requires proper patient selection and an experienced operator.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Farhan Quader and C. Prakash Gyawali contributed equally to this work.

Authors and Affiliations

  1. Division of Gastroenterology, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8124, Saint Louis, MO, 63110, USA

    Farhan Quader MD & C. Prakash Gyawali MD

Authors
  1. Farhan Quader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Prakash Gyawali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Prakash Gyawali MD.

Ethics declarations

Conflict of Interest

Farhan Quader declares that he has no conflict of interest.

C. Prakash Gyawali. Consulting: Ironwood, Torax, Quintiles, Isothrive; Teaching and speaking: Medtronic, Diversatek.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Esophagus

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Quader, F., Gyawali, C.P. 7RECENT Advances in Endoscopic Treatments for Gastroesophageal Reflux Disease. Curr Treat Options Gastro 18, 504–517 (2020). https://doi.org/10.1007/s11938-020-00301-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-020-00301-2

Keywords

Search

Navigation